Paradigm Biocapital Advisors LP

Holdings History for LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Symbol: LENZ on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Shares Owned: 1,073,461 shares
Security Ownership %: 3.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

14 Nov 2025 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,073,461 shares of LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ). This represents 3.8% ownership of the company. In their previous filing dated 27 Mar 2025, Paradigm Biocapital Advisors LP had reported owning 1,419,832 shares, indicating a decrease of +24%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Paradigm BioCapital Advisors LP	3.8%	-28%	$50,001,813	1,073,461	-346,371	-24%	$46.58	13G/A	30 Sep 2025	14 Nov 2025, 16:32
Paradigm BioCapital Advisors LP	5.2%		$26,323,685	1,419,832			$18.54	13G	20 Mar 2025	27 Mar 2025, 16:21

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025	1.5%	-0.89%	$50,001,813	1,073,461	-643,605	-37%	$46.58	Q3 2025
30 Jun 2025	2.1%	+0.26%	$50,327,204	1,717,066	+205,134	+14%	$29.31	Q2 2025
31 Mar 2025	1.8%	+0.88%	$38,871,772	1,511,932	+741,477		$25.71	Q1 2025
31 Dec 2024	0.77%	+0.77%	$22,243,036	770,455	+770,455	NEW	$28.87	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.